Market Update:

As the clock strikes midday, the atmosphere on Wall Street is one of cautious optimism. The major stock market indices have managed to find some stability amidst the turbulence that characterized the morning trading session. Investors are closely monitoring the market, eager to sustain the positive momentum that was kickstarted by yesterday's rally, which acted as a reassuring balm following the minor crash earlier in the week. The technology and healthcare sectors are buzzing with activity today, with Eli Lilly (LLY) basking in the glow of its favorable earnings report and chipmaker Broadcom (AVGO) also making significant strides.

Despite the sense of calm that seems to have settled over the market, remnants of the recent turbulence are still visible. Small-cap stocks, in particular, are struggling to keep pace with the broader market, with the Russell 2000 index finding it challenging to break through its 50-day moving average. The aftermath of Monday's sharp decline continues to cast a shadow, with many stocks bracing themselves for what could be a week marked by losses.

While the domestic economic front has been relatively quiet this morning, unexpected inflation reports from China have sent ripples across global risk assets. The upcoming U.S. Consumer Price Index (CPI) release next week is eagerly anticipated, especially in light of the recent developments in China. Interestingly, Treasury yields have taken a surprising turn, falling for the first time in four days. This shift comes on the heels of hints from several Federal Reserve officials about a potential rate cut in September, a topic expected to be further explored at the upcoming Fed symposium in Jackson Hole.

Summary:

Our portfolio has consistently outperformed the market by a considerable margin, showcasing a robust positioning for sustained growth. Leveraging our advanced technical analysis methods, we accurately predicted a potential surge in NTRA. Despite the overall market's lackluster performance, today marked a significant upturn in the stock's value, validating our foresight. This success underscores the effectiveness of our strategic approach and highlights the importance of timely decision-making in the dynamic world of investments. Congratulations on this achievement, which reaffirms our commitment to delivering superior results for our SBN Members both in the short and long term!

Selling Guidelines:

• If you wish to continue owning this stock, you may choose to depending on your overall portfolio distribution

• You may even consider doing a partial sale.

• If you do not own this stock, no action is required at this time.

Sell Pick No: 303

VIEW STOCK PICK

If you liked/owned this pick and/or plan to close your position, please press the Like (Heart) Button below the post.

Keep Buzzing!